The main findings of this study are that a score based on the integration of three biomarkers, i.e., NT-proBNP, Gal-3, and ST2, provides better prognostic stratification for predicting short and mid-term occurrence of heart failure progression, thus suggesting the possible usefulness of this simple approach in clinical practice. The gene discussed is NPPB; the disease is heart failure.